These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 35750765)

  • 1. Circ-HSP90A expedites cell growth, stemness, and immune evasion in non-small cell lung cancer by regulating STAT3 signaling and PD-1/PD-L1 checkpoint.
    Lei J; Zhu J; Hui B; Jia C; Yan X; Jiang T; Wang X
    Cancer Immunol Immunother; 2023 Jan; 72(1):101-124. PubMed ID: 35750765
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circular RNA circ-CPA4/ let-7 miRNA/PD-L1 axis regulates cell growth, stemness, drug resistance and immune evasion in non-small cell lung cancer (NSCLC).
    Hong W; Xue M; Jiang J; Zhang Y; Gao X
    J Exp Clin Cancer Res; 2020 Aug; 39(1):149. PubMed ID: 32746878
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circular RNA hsa_circ_0000190 Facilitates the Tumorigenesis and Immune Evasion by Upregulating the Expression of Soluble PD-L1 in Non-Small-Cell Lung Cancer.
    Luo YH; Yang YP; Chien CS; Yarmishyn AA; Adekunle Ishola A; Chien Y; Chen YM; Tsai PH; Lin TW; Wang ML; Chiou SH
    Int J Mol Sci; 2021 Dec; 23(1):. PubMed ID: 35008490
    [TBL] [Abstract][Full Text] [Related]  

  • 4. N
    Liu Z; Wang T; She Y; Wu K; Gu S; Li L; Dong C; Chen C; Zhou Y
    Mol Cancer; 2021 Aug; 20(1):105. PubMed ID: 34416901
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CircFOXK2 enhances tumorigenesis and immune evasion in non-small cell lung cancer by miR-485-5p/PD-L1 axis.
    Zhang N; Fan J; Deng Z
    Anticancer Drugs; 2022 Jun; 33(5):437-447. PubMed ID: 35324518
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circular RNA hsa_circ_0068252 Functions in Cisplatin Resistance and Immune Response via miR-1304-5p/PD-L1 Axis in Non-Small Cell Lung Cancer.
    Li J; Xu J; Wu G; Ren Y; Wang X; Zhang Q
    Chemotherapy; 2022; 67(4):223-233. PubMed ID: 35649347
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circ_0076305 regulates cisplatin resistance of non-small cell lung cancer via positively modulating STAT3 by sponging miR-296-5p.
    Dong Y; Xu T; Zhong S; Wang B; Zhang H; Wang X; Wang P; Li G; Yang S
    Life Sci; 2019 Dec; 239():116984. PubMed ID: 31647948
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circ_0014235 confers Gefitinib resistance and malignant behaviors in non-small cell lung cancer resistant to Gefitinib by governing the miR-146b-5p/YAP/PD-L1 pathway.
    Niu R; Li D; Chen J; Zhao W
    Cell Cycle; 2022 Jan; 21(1):86-100. PubMed ID: 34919024
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunomodulatory functions of the circ_001678/miRNA-326/ZEB1 axis in non-small cell lung cancer via the regulation of PD-1/PD-L1 pathway.
    Tian Q; Wu T; Zhang X; Xu K; Yin X; Wang X; Shi S; Wang P; Gao L; Xu S; Liu X
    Hum Mol Genet; 2022 Nov; 31(23):4094-4106. PubMed ID: 35848890
    [TBL] [Abstract][Full Text] [Related]  

  • 10. hsa_circ_0003222 accelerates stemness and progression of non-small cell lung cancer by sponging miR-527.
    Li C; Zhang J; Yang X; Hu C; Chu T; Zhong R; Shen Y; Hu F; Pan F; Xu J; Lu J; Zheng X; Zhang H; Nie W; Han B; Zhang X
    Cell Death Dis; 2021 Aug; 12(9):807. PubMed ID: 34433810
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circular RNA circ_0003028 contributes to tumorigenesis by regulating GOT2 via miR-1298-5p in non-small cell lung cancer.
    Guan H; Sun C; Gu Y; Li J; Ji J; Zhu Y
    Bioengineered; 2021 Dec; 12(1):2326-2340. PubMed ID: 34077306
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circ_0067934 promotes non-small cell lung cancer development by regulating miR-1182/KLF8 axis and activating Wnt/β-catenin pathway.
    Zhao M; Ma W; Ma C
    Biomed Pharmacother; 2020 Sep; 129():110461. PubMed ID: 32768951
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exosomal circ_PIP5K1A regulates the progression of non-small cell lung cancer and cisplatin sensitivity by miR-101/ABCC1 axis.
    Shao N; Song L; Sun X
    Mol Cell Biochem; 2021 Jun; 476(6):2253-2267. PubMed ID: 33570734
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CircRNA VIM silence synergizes with sevoflurane to inhibit immune escape and multiple oncogenic activities of esophageal cancer by simultaneously regulating miR-124/PD-L1 axis.
    Gao C; Xu YJ; Qi L; Bao YF; Zhang L; Zheng L
    Cell Biol Toxicol; 2022 Oct; 38(5):825-845. PubMed ID: 34018092
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Depletion of circ-BIRC6, a circular RNA, suppresses non-small cell lung cancer progression by targeting miR-4491.
    Jin Z; Gao B; Gong Y; Guan L
    Biosci Trends; 2021 Jan; 14(6):399-407. PubMed ID: 33177288
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hsa_circ_0006677 regulates special AT-rich binding protein-2-mediated tumor-suppressive effect via functioning as a miR-1245a sponge in non-small cell lung cancer.
    Sui X; Liu Z; Niu L; Yin B; Huo C
    Bioengineered; 2022 Feb; 13(2):3760-3774. PubMed ID: 35081869
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circular RNA hsa_circ_0005239 contributes to hepatocellular carcinoma cell migration, invasion, and angiogenesis by targeting the miR-34a-5p/PD-L1 axis.
    He T; Huang J; Liang H; Zhong B; Xu G; Zhu X
    Cell Biol Int; 2023 Sep; 47(9):1519-1534. PubMed ID: 37208963
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circ_0089823 reinforces malignant behaviors of non-small cell lung cancer by acting as a sponge for microRNAs targeting SOX4
    Li J; Zhu Z; Li S; Han Z; Meng F; Wei L
    Neoplasia; 2021 Sep; 23(9):887-897. PubMed ID: 34311177
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circular RNA circ-CMPK1 contributes to cell proliferation of non-small cell lung cancer by elevating cyclin D1 via sponging miR-302e.
    Cui D; Qian R; Li Y
    Mol Genet Genomic Med; 2020 Feb; 8(2):e999. PubMed ID: 31863641
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hsa_circ_0136666 activates Treg-mediated immune escape of colorectal cancer via miR-497/PD-L1 pathway.
    Xu YJ; Zhao JM; Gao C; Ni XF; Wang W; Hu WW; Wu CP
    Cell Signal; 2021 Oct; 86():110095. PubMed ID: 34320370
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.